Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias (EPICONTAC-VT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01847378 |
Recruitment Status
: Unknown
Verified October 2014 by Lucas Hollanda, Federal University of São Paulo.
Recruitment status was: Recruiting
First Posted
: May 6, 2013
Last Update Posted
: October 21, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Ventricular tachycardia is one of the commonest cause of sudden death in chronic chagas disease. As most ventricular tachycardias originate from scar in patients with heart disease, catheter ablation is an important step in patient treatment. Identification of fibrosis prior to ablation of sustained ventricular tachycardia (SVT) might reduce the time of anesthesia, procedure time, radiation exposure and possibly the risk of complications. Knowledge of arrhythmia circuit within scar allows planning strategies for each procedure. Condreanu et al. stablished that voltages inferior to 6.52 mV (unipolar) and 1.54mV (bipolar) are useful tools in detecting scar during electroanatomic mapping. Accuracy, however when compared to magnetic resonance imaging is limited due to difficulties in maintaining good contact between ablation catheter and ventricular wall. Contact force catheters might help increase accuracy of voltage mapping because they allow detection of poor contact areas. Although the threshold for identification of scar in ischemic and non ischemic patients during electroanatomical mapping is already known, this parameters still lacking for chronic chagasic individuals. A marked qualitative histological difference between these fibrous scars supports the hypothesis that voltage scar in chagasics might be different. Catheter ablation contact with endo and epicardial surface is an important issue when ablating arrhythmias. Conventional catheter ablation is not equipped with sensors capable of detecting degree of contact with the target. To our knowledge, the literature lacks information in regard to late lesions produced by a known contact force pressure "in vivo". The pattern of electrical activation in these patients and their relationship with local coronary veins for resynchronization likely to approach through the coronary sinus can be useful in defining chagasic that can benefit from resynchronization.
- Compare endocardial and epicardial impedance and voltage using CARTO 3 with fibrosis on 3T MRI
- Correlate areas of late activation within scar during activating mapping in sinus rhythm with different signal intensity in 3T MRI
- Evaluate the influence of contact pressure during application of radiofrequency in making fibrosis analyzed 30 days after the procedure using a 3T MRI.
- Assess the site of latest left ventricular activation in sinus rhythm and correlate with the coronary veins location
Condition or disease | Intervention/treatment |
---|---|
Ventricular Tachycardia Sudden Death Syncope Chest Pain | Procedure: Catheter ablation |
Study Type : | Observational |
Estimated Enrollment : | 10 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | EPIcardial and Endocardial Mapping and Ablation Using Contact Force Catheter in Chagasic Patients With Sustained Ventricular Tachycardia |
Study Start Date : | June 2013 |
Estimated Primary Completion Date : | May 2015 |
Estimated Study Completion Date : | August 2015 |
Group/Cohort | Intervention/treatment |
---|---|
Catheter ablation
Patients with chronic chagasic disease and documented monomorphic ventricular tachycardia
|
Procedure: Catheter ablation
During mapping and ablation tissue voltage and impedance will be stored and analyzed thereafter. The same procedure will be done in regard to activating maps.
|
- Evaluate the feasibility of mapping and ablating ventricular tachycardias in endocardial and epicardial using a contact force catheter [ Time Frame: Immediatly after the procedure ]The feasibility will be evaluated immediatly after the procedure
- Evaluate the impedance and voltage threshold for scar in chronic chagasic cardiomyopathy [ Time Frame: After the procedure ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- individuals aged between 18 and 80 years old
- life expectancy greater than 1 year
- positive reaction in at least two different serologic techniques for Chagas disease (ELISA, indirect hemagglutination or indirect immunofluorescence)
- symptomatic recurrent monomorphic ventricular tachycardia (recorded by holter, electrocardiogram or looper)
- prior to implantable cardioverter defibrillator implantation in patients with ventricular tachycardia as an attempt to prevent shoks
- patients in "electrical storm", defined as three or more episodes of ventricular tachycardia in 24h. Each episode must demand a medical intervention.
- monomorphic ventricular tachycardia induced during electrical physiological study in patients with syncope of unexplained cause
Exclusion Criteria:
- claustrophobia
- creatinine clearance inferior to 30ml/min/m2 (clearance between 30ml/min/m2 and 60ml/min/m2 will be analyzed individually)
- thrombus in the left ventricle
- pregnancy
- heart failure NYHA IV
- allergy to iodinated contrast or gadolinium
- patients with implantable devices (pacemakers, implantable defibrillators and similar)
- coagulopathy (INR > 1,5 or aPTT 2x normal values)
- platelet count inferior to 100.000

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01847378
Contact: Lucas H Oliveira, MD | +55(11)99750937 ext 55 | lucas.hollanda@unifesp.br | |
Contact: Enia L Coutinho, Coordinator | +55(11)992914070 | coutinho.enia@gmail.com |
Brazil | |
Federal University of São Paulo, São Paulo Hospital | Recruiting |
São Paulo, Brazil, 04024-002 | |
Contact: Enia L Coutinho, coordinator +55(11)992914070 coutinho.enia@gmail.com | |
Principal Investigator: Lucas H Oliveira, MD | |
Federal University of São Paulo | Recruiting |
São Paulo, Brazil, 04024-002 | |
Contact: Lucas H Oliveira, MD, Msc +55(11)99975-0937 lucas.hollanda@unifesp.br | |
Sub-Investigator: Angelo AV de Paola, MD, pHD | |
Sub-Investigator: Claudio Cirenza, MD, pHD | |
Federal University of São Paulo | Not yet recruiting |
São Paulo, Brazil, SP | |
Contact: Enia L Coutinho, Coordinator +55(11)992914070 coutinho.enia@gmail.com | |
Principal Investigator: Lucas H Oliveira, MD |
Study Director: | Claudio Cirenza, MD, PhD | Federal University of São Paulo | |
Study Chair: | Angelo AV de Paola, MD, PhD | Federal University of São Paulo | |
Principal Investigator: | Lucas H Oliveira, MD | Federal University of São Paulo |
Responsible Party: | Lucas Hollanda, MD, Federal University of São Paulo |
ClinicalTrials.gov Identifier: | NCT01847378 History of Changes |
Other Study ID Numbers: |
ISII |
First Posted: | May 6, 2013 Key Record Dates |
Last Update Posted: | October 21, 2014 |
Last Verified: | October 2014 |
Keywords provided by Lucas Hollanda, Federal University of São Paulo:
ventricular tachycardia catheter ablation chagas disease epicardial mapping magnetic resonance imaging |
Additional relevant MeSH terms:
Tachycardia Chest Pain Syncope Tachycardia, Ventricular Death, Sudden Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |
Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms Unconsciousness Consciousness Disorders Neurobehavioral Manifestations Death |